Cite
HARVARD Citation
Schoenmaekers, J. et al. (n.d.). 1365PDScreening for brain metastases (BM) in patients (pts) with stage III non-small cell lung cancer (NSCLC), magnetic resonance imaging (MRI) or dedicated contrast-enhanced computed tomography (dCE-CT)? A prospective observational study. Annals of oncology. p. . [Online].